Advertisement
Screener

SCICLONE PHARMACEUTICALS INC Net Cash Provided by (Used in) Operating Activities, Continuing Operations

SCICLONE PHARMACEUTICALS INC Net Cash Provided by (Used in) Operating Activities, Continuing Operations

SCICLONE PHARMACEUTICALS INC reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of $20.34 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-09.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2017-08-09

  • SCICLONE PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-06-30 was $14.70M, a 138.43% increase year-over-year.
  • SCICLONE PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-03-31 was $5.63M, a 56.51% decline year-over-year.
  • SCICLONE PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-12-31 was $3.57M, a 66.74% increase year-over-year.
  • SCICLONE PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-09-30 was $11.83M, a 12.56% decline year-over-year.
  • SCICLONE PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was $34.53M, a 6.21% increase from fiscal 2015.
  • SCICLONE PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was $32.51M, a 17.74% increase from fiscal 2014.
  • SCICLONE PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was $27.61M, a 190.56% increase from fiscal 2013.
  • SCICLONE PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for fiscal 2013 was $9.50M, a 78.17% decline from fiscal 2012.
Period endNet Cash Provided by (Used in) Operating Activities, Continuing Operations 3 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 9 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month
2017-06-30$14.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$20.34M
10-Q · filed 2017-08-09
$23.91M
derived: sum of 3 quarters · filed 2017-08-09
$35.74M
derived: sum of 4 quarters · filed 2017-08-09
2017-03-31$5.63M
10-Q · filed 2017-05-10
$9.21M
derived: sum of 2 quarters · filed 2017-05-10
$21.04M
derived: sum of 3 quarters · filed 2017-05-10
$27.20M
derived: sum of 4 quarters · filed 2017-08-09
2016-12-31$3.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
$15.40M
derived: sum of 2 quarters · filed 2017-03-09
$21.57M
derived: sum of 3 quarters · filed 2017-08-09
$34.53M
10-K · filed 2017-03-09
2016-09-30$11.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$18.00M
derived: sum of 2 quarters · filed 2017-08-09
$30.96M
10-Q · filed 2016-11-09
$33.10M
derived: sum of 4 quarters · filed 2017-08-09
2016-06-30$6.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$19.13M
10-Q · filed 2017-08-09
$21.27M
derived: sum of 3 quarters · filed 2017-08-09
$34.80M
derived: sum of 4 quarters · filed 2017-08-09
2016-03-31$12.96M
10-Q · filed 2017-05-10
$15.10M
derived: sum of 2 quarters · filed 2017-05-10
$28.63M
derived: sum of 3 quarters · filed 2017-05-10
$33.17M
derived: sum of 4 quarters · filed 2017-05-10
2015-12-31$2.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
$15.67M
derived: sum of 2 quarters · filed 2017-03-09
$20.21M
derived: sum of 3 quarters · filed 2017-03-09
$32.51M
10-K · filed 2017-03-09
2015-09-30$13.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$18.07M
derived: sum of 2 quarters · filed 2016-11-09
$30.37M
10-Q · filed 2016-11-09
$31.52M
derived: sum of 4 quarters · filed 2017-03-09
2015-06-30$4.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$16.84M
10-Q · filed 2016-08-09
$17.99M
derived: sum of 3 quarters · filed 2017-03-09
$33.83M
derived: sum of 4 quarters · filed 2017-03-09
2015-03-31$12.29M
10-Q · filed 2016-05-10
$13.45M
derived: sum of 2 quarters · filed 2017-03-09
$29.29M
derived: sum of 3 quarters · filed 2017-03-09
$35.79M
derived: sum of 4 quarters · filed 2017-03-09
2014-12-31$1.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
$17.00M
derived: sum of 2 quarters · filed 2017-03-09
$23.49M
derived: sum of 3 quarters · filed 2017-03-09
$27.61M
10-K · filed 2017-03-09
2014-09-30$15.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$22.34M
derived: sum of 2 quarters · filed 2015-11-09
$26.45M
10-Q · filed 2015-11-09
$24.11M
derived: sum of 4 quarters · filed 2016-03-11
2014-06-30$6.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
$10.61M
10-Q · filed 2015-08-10
$8.27M
derived: sum of 3 quarters · filed 2016-03-11
$27.76M
derived: sum of 4 quarters · filed 2016-03-11
2014-03-31$4.12M
10-Q · filed 2015-05-11
$1.78M
derived: sum of 2 quarters · filed 2016-03-11
$21.27M
derived: sum of 3 quarters · filed 2016-03-11
$2.69M
derived: sum of 4 quarters · filed 2016-03-11
2013-12-31-$2.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11
$17.15M
derived: sum of 2 quarters · filed 2016-03-11
-$1.43M
derived: sum of 3 quarters · filed 2016-03-11
$9.50M
10-K · filed 2016-03-11
2013-09-30$19.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$910.00K
derived: sum of 2 quarters · filed 2014-11-10
$11.84M
10-Q · filed 2014-11-10
$14.41M
derived: sum of 4 quarters · filed 2015-03-12
2013-06-30-$18.58M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
-$7.65M
10-Q · filed 2014-08-11
-$5.08M
derived: sum of 3 quarters · filed 2015-03-12
2013-03-31$10.93M
10-Q · filed 2014-05-12
$13.50M
derived: sum of 2 quarters · filed 2015-03-12
2012-12-31$2.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
$43.52M
10-K · filed 2015-03-12
2012-09-30$40.95M
10-Q · filed 2013-11-12